News

The lactate measurements from the epoc System are used to evaluate acid-base status and for diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood). The

Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated

As part of these conditions, GSK is expected to provide data from ongoing clinical studies. Earlier, FDA has approved the use of Votrient (pazopanib) as a treatment for

As per the terms of the agreement, Sapient Discovery is expected to apply its proprietary structural biology platform and expertise to determine the three-dimensional structures for targets of

Cytokine results of the dose-finding study in pregnant women at term gestation confirmed the efficacy and safety of its investigational product and suggested that the MVI may reduce

In 2006, Mr Grant began his tenure as Allergan’s corporate vice president and president. Prior to that he has served as acting chairman, president and CEO of Biolase

Teva’s product is sold as a generic version of Bayer HealthCare’s oral contraceptive YAZ, a progesterone and estrogen combination birth control pill. It works by preventing ovulation, thickening

Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings. As per the agreement, Norgine is expected to make an upfront

Pieris said that the trial is designed to test PRS-050 in approximately 40 patients, who will receive the compound and then be monitored for safety and tolerability. The